Rational pharmacotherapy in modern gastroenterology
https://doi.org/10.21518/2079-701X-2021-15-13-18
Abstract
Abstract Introduction. Modern gastroenterology is characterized by the combined (comorbid) nature of the diseases. In treatment, this promotes polypharmacy and increases complications (drug lesions, allergic reactions, exacerbation of diseases of other organs and systems), and, importantly, increases the cost of pharmacotherapy.
Aim. To compare two pharmacotherapy options for patients with gallstone disease at the stage of biliary sludge and patients with biliary sludge combined with irritable bowel syndrome.
Materials and methods. In the work, based on the experience of treating 170 patients, two options for pharmacotherapy are considered, which may well turn out to be rational in all respects. Option 1 - monotherapy aimed at one of the components that form a complex pathogenetic symptom complex. The basis for offering this treatment option is the biological concept of the “regulatory cascade”. Option 2 – “stepwise” (stepwise) therapy with the choice of the “base” drug for the first step. Evaluation of the effectiveness and rational correction for the second step of treatment and subsequent ones – if necessary.
Results. The biliary sludge was eliminated or reduced in patients who received the UDCA monotherapy against the background of recovery of gastrointestinal motility. The overall treatment effect (for each nosology) in patients with biliary sludge and irritable bowel syndrome using the complex therapy (UDCA and mebeverin) was 84 and 87.8% respectively.
Conclusions. Both options are rational today: 1st requires further study; 2nd – active use. Both options exclude polypharmacy and other adverse effects.
About the Author
O. N. Minushkin
Central State Medical Academy of the Presidential
Administration of the Russian Federation
Russian Federation
Russian Federation
Dr. Sci. (Med.), Professor, Head of the Department of Gastroenterology
19, Bldg. 1A, Marshal Timoshenko St., Moscow, 121359
References
1. Maev I.V., Bordin D.S., Eremina E.Yu., Ilchishina T.A., Kaibysheva V.O., Osipenko M.F. et al. Irritable Bowel Syndrome. Modern Aspects of Epidemiology, Pathogenesis And Treatment (A Review). Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2018;(10):68–73. (In Russ.) Available at: https://www.nogr.org/jour/article/view/1064.
2. Samsonov A.A., Semenova A.V., Andreyev D.N., Goncharenko A.Yu., Lobanova E.G., Kuznetsova E.I. Overlap Syndrome of Functional Dispepsia and Irritable Bowel Syndrome: Up-to-Date State of the Problem. Farmateka. 2018;(2):13–17. (In Russ.) https://doi.org/10.18565/pharmateca.2018.2.13-17.
3. Ivashkin V.T., Poluektova Y.A., Reykhart D.V., Shifrin O.S., Beniashvili A.G., Lyashenko O.S., Belostotsky A.V. Efficacy of Drugs Most Commonly Prescribed at Functional Gastrointestinal Diseases (Functional Dyspepsia Syndrome and Irritable Bowel Syndrome) Observational Study Results. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(4):14–23. (In Russ.) Available at: https://www.gastro-j.ru/jour/article/view/68.
4. Drossman D.A., Hasler W.L. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257–1261. https://doi.org/10.1053/j.gastro.2016.03.035.
5. Maslovsky L.V. Diagnostics and Treatment of Biliary Sludge. In: Minushkin O.N. (ed.) Diseases of the Gastrointestinal Tract: Diagnosis and Treatment: Materials of the Scientific and Practical Conference. Moscow, May 26, 2021. Moscow; 2021, pp. 23–27. (In Russ.).
6. Minushkin O.N. Gallstone Disease in the Sludge Stage. Therapeutic Approaches. In: Minushkin O.N. (ed.) Diseases of the Gastrointestinal Tract: Diagnosis and Treatment: Materials of the Scientific and Practical Conference. Moscow, May 26, 2021. Moscow; 2021. pp, 38–49. (In Russ.).
7. Minushkin O.N., Burdina E.G., Novozhyonova E.V. Biliary sludge. Epidemiology, Risk Factors, Formation, Diagnosis, Treatment Approaches. Meditsinskiy alfavit = Medical Alphabet. 2017;2(19):5–8. (In Russ.) Available at: https://www.med-alphabet.com/jour/article/viewFile/222/222.
8. Singh G., Triadafilopoulos G. Appropriate Choice of Proton Pump Inhibitor Therapy in the Prevention and Management of NSAID-Related Gastrointestinal Damage. Int J Clin Pract. 2005;59(10):1210– 1217 https://doi.org/10.1111/j.1368-5031.2005.00660.x.
9. Minushkin O.N., Burdina E.G., Novozhonova E.V., Vasilchenko S.A., Gurova N.Yu. Biliary Sludge: Diagnosis and Treatment at an Outpatients Clinic. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2013;(9):14–20. (In Russ.) Available at: https://elibrary.ru/item.asp?id=21440309.
Review
For citations:
Minushkin ON. Rational pharmacotherapy in modern gastroenterology. Meditsinskiy sovet = Medical Council. 2021;(15):13-18. (In Russ.) https://doi.org/10.21518/2079-701X-2021-15-13-18
Views:
616
Email this article 